In one paragraphArticle in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
14 authors.
Fan Wu *State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Diseases, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.ORCID https://orcid.org/0000-0003-0720-4674 Zhishan DengState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Diseases, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.ORCID https://orcid.org/0000-0003-3652-5493 Qi WanState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Diseases, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.ORCID https://orcid.org/0000-0003-1277-0910 Gaoying TangState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Diseases, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.ORCID https://orcid.org/0000-0003-0953-5303 Lifei LuState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Diseases, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.ORCID https://orcid.org/0000-0003-0300-9011 Kunning ZhouState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Diseases, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.ORCID https://orcid.org/0000-0002-2805-9317 Cuiqiong DaiState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Diseases, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.ORCID https://orcid.org/0000-0003-2439-3200 Jieqi PengState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Diseases, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.ORCID https://orcid.org/0000-0002-9638-4015 Xiaohui WuState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Diseases, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.ORCID https://orcid.org/0000-0002-9856-6912 Pixin RanState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Diseases, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.ORCID https://orcid.org/0000-0001-6651-634X Yumin ZhouState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Diseases, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.ORCID https://orcid.org/0000-0002-0555-8391 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Background: Lung function trajectories in chronic obstructive pulmonary disease (COPD) vary among individuals. However, evidence on the clinical characteristics and prognosis of mild-to-moderate COPD developing from different lung function trajectories is limited. We aim to explore whether differences exist in the clinical features and prognosis of mild-to-moderate COPD developed through different lung function trajectories. Methods: Individuals who participated in the Early COPD study (2019-2020) and who had available spirometry data from the China Epidemiological Survey of COPD (2012-2013) were included and categorized into three groups: (I) previously normal forced expiratory volume in one second (FEV Results: Overall, 96 participants were included in the previously normal FEV Conclusions: There were significant differences in the clinical characteristics and longitudinal prognosis of mild-to-moderate COPD progressing from different pulmonary function trajectories, reflecting the need for individualized management.
Indexed as
acute exacerbationchronic obstructive pulmonary disease (COPD)Lung function declinemild-to-moderatespirometry
Identifiers
PMID42182753
PMCPMC13190149
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390